共 38 条
[1]
Andersen L.K., Jensen H.K., Juul S., Faergeman O., Patients’ attitudes toward detection of heterozygous familial hypercholesterolemia, Arch Intern Med, 157, pp. 553-560, (1997)
[2]
Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G., Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication, J Clin Endocrinol Metab, 97, pp. 3956-3964, (2012)
[3]
Bensen J.T., Liese A.D., Rushing J.T., Et al., Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS), Genet Epidemiol, 17, pp. 141-150, (1999)
[4]
Risk Of Fatal Coronary Heart Disease In Familial Hypercholesterolaemia, BMJ, pp. 893-896, (1991)
[5]
Forrest K., Simpson S., Wilson B., Et al., To tell or not to tell: barriers and facilitators in family communication about genetic risk, Clin Genet, 64, pp. 317-326, (2003)
[6]
Gaff C.L., Collins V., Symes T., Halliday J., Facilitating family communication about predictive genetic testing: probands’ perceptions, J Genet Couns, 14, pp. 133-140, (2005)
[7]
Go A.S., Mozaffarian D., Roger V.L., Et al., Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, pp. e28-e292, (2014)
[8]
Goldberg A.C., Hopkins P.N., Toth P.P., Et al., Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia, J Clin Lipidol, 5, pp. S1-S8, (2011)
[9]
Goldstein J., Hobbs H., Brown M., Familial hypercholesterolemia, (2001)
[10]
Group. SSC on behalf of the SBR S.B.R., Risk of fatal coronary heart disease in familial hypercholesterolemia, BMJ, 303, pp. 893-896, (1991)